Seres Therapeutics Files 8-K on Financials
Ticker: MCRB · Form: 8-K · Filed: May 7, 2025 · CIK: 1609809
| Field | Detail |
|---|---|
| Company | Seres Therapeutics, Inc. (MCRB) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, sec-filing
Related Tickers: MCRB
TL;DR
Seres Therapeutics filed an 8-K on May 7, 2025, updating on financials and operations.
AI Summary
On May 7, 2025, Seres Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, along with Regulation FD disclosures and financial statements. No specific financial figures or operational updates were detailed in the provided excerpt.
Why It Matters
This filing indicates Seres Therapeutics is providing an update on its financial status and operational results to the SEC, which is important for investors to monitor the company's performance.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report detailing financial condition and operations, without immediate news of significant events.
Key Players & Entities
- Seres Therapeutics, Inc. (company) — Registrant
- May 7, 2025 (date) — Date of Report
- 001-37465 (company) — Commission File Number
- 27-4326290 (company) — IRS Employer Identification No.
- 101 Cambridgepark Drive (location) — Address of principal executive offices
- Cambridge, MA (location) — City, State of principal executive offices
- 02140 (location) — Zip Code of principal executive offices
- (617) 945-9626 (phone_number) — Registrant's telephone number
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided excerpt of the 8-K filing does not detail specific financial results or operational updates; it only states that the filing pertains to 'Results of Operations and Financial Condition'.
What is the exact date of the earliest event reported in this 8-K?
The date of the earliest event reported in this 8-K is May 7, 2025.
What is the Commission File Number for Seres Therapeutics, Inc.?
The Commission File Number for Seres Therapeutics, Inc. is 001-37465.
Where are Seres Therapeutics, Inc.'s principal executive offices located?
Seres Therapeutics, Inc.'s principal executive offices are located at 101 Cambridgepark Drive, Cambridge, MA 02140.
What is the IRS Employer Identification Number for Seres Therapeutics, Inc.?
The IRS Employer Identification Number for Seres Therapeutics, Inc. is 27-4326290.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding Seres Therapeutics, Inc. (MCRB).